Abstract
In a masked, randomized, concurrently controlled clinical trial we compared the therapeutic response of two regimens in which the same topical corticoid was used to treat 52 men who had stable psoriasis. One regimen, called reduced dose, consisted of once-a-day application of a representative potent fluorinated topical steroid ointment, fluocinonide (Lidex), combined with three-times-a-day application of its vehicle. The other regimen, called traditional dose, consisted of four-times-a-day topical application of the same steroid. Patients were assigned to one of the two regimens and observed for six weeks. Confidence intervals for the difference in true mean response under these two regimens provide good evidence that for these patients the traditional dose was not clinically superior to the reduced dose.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Binder R., McCleary J. Comparison of fluocinonide in a double-blind study with betamethasone valerate. Curr Ther Res Clin Exp. 1972 Jan;14(1):35–38. [PubMed] [Google Scholar]
- Cornell R. C., Stoughton R. B. Use of glucocorticosteroids in psoriasis. Pharmacol Ther. 1980;11(3):497–508. doi: 10.1016/0163-7258(80)90039-x. [DOI] [PubMed] [Google Scholar]
- Gatley M. S. To be taken as directed. J R Coll Gen Pract. 1968 Jul;16(1):39–44. [PMC free article] [PubMed] [Google Scholar]
- JENKINS B. W. Are patients true to t.i.d. and q.i.d. doses? GP. 1954 Jun;9(6):66–69. [PubMed] [Google Scholar]
- Kirby J. D., Munro D. D. Steroid-induced atrophy in an animal and human model. Br J Dermatol. 1976 Mar;94 Suppl 12:111–119. doi: 10.1111/j.1365-2133.1976.tb02279.x. [DOI] [PubMed] [Google Scholar]
- Maibach H. I., Stoughton R. B. Topical corticosteroids. Med Clin North Am. 1973 Sep;57(5):1253–1264. doi: 10.1016/s0025-7125(16)32226-x. [DOI] [PubMed] [Google Scholar]
- Porter A. M. Drug defaulting in a general practice. Br Med J. 1969 Jan 25;1(5638):218–222. doi: 10.1136/bmj.1.5638.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Portnoy B., Sarkany I. "Metosyn" in psoriasis and eczema. Br J Dermatol. 1972 Mar;86(3):310–311. doi: 10.1111/j.1365-2133.1972.tb02236.x. [DOI] [PubMed] [Google Scholar]
- Rosenberg E. W. Fluocinonide. Preliminary evaluation of a new topically applied corticosteroid. Arch Dermatol. 1971 Dec;104(6):632–633. doi: 10.1001/archderm.104.6.632. [DOI] [PubMed] [Google Scholar]
- Sneddon I. Adverse effect of topical fluorinated corticosteroids in rosacea. Br Med J. 1969 Mar 15;1(5645):671–673. doi: 10.1136/bmj.1.5645.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stoughton R. B. Bioassay system for formulations of topically applied glucocorticosteroids. Arch Dermatol. 1972 Dec;106(6):825–827. [PubMed] [Google Scholar]
- Sudilovsky A., Muir J. G., Bocobo F. C. A comparison of single and multiple applications of halcinonide cream. Int J Dermatol. 1981 Nov;20(9):609–613. doi: 10.1111/j.1365-4362.1981.tb00847.x. [DOI] [PubMed] [Google Scholar]
- Wilson L. The clinical assessment of topical corticosteroid activity. Br J Dermatol. 1976 Mar;94 Suppl 12:33–42. doi: 10.1111/j.1365-2133.1976.tb02267.x. [DOI] [PubMed] [Google Scholar]
- du Vivier A., Phillips H., Hehir M. Applications of glucocorticosteroids. The effects of twice-daily vs once-every-other-day applications on mouse epidermal cell DNA synthesis. Arch Dermatol. 1982 May;118(5):305–308. doi: 10.1001/archderm.118.5.305. [DOI] [PubMed] [Google Scholar]
- du Vivier A. Tachyphylaxis to topically applied steroids. Arch Dermatol. 1976 Sep;112(9):1245–1248. doi: 10.1001/archderm.112.9.1245. [DOI] [PubMed] [Google Scholar]